 Adwitiya Kar
Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenocortical Carcinoma | 6 | 2021 | 51 | 2.100 |
Why?
| | Proto-Oncogene Proteins c-ets | 3 | 2020 | 57 | 1.860 |
Why?
| | Receptor, ErbB-2 | 3 | 2020 | 323 | 1.320 |
Why?
| | Adrenal Cortex Neoplasms | 4 | 2021 | 50 | 1.260 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1392 | 0.900 |
Why?
| | Transcription Factors | 2 | 2020 | 1628 | 0.780 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2020 | 189 | 0.730 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 121 | 0.710 |
Why?
| | Trastuzumab | 2 | 2019 | 97 | 0.670 |
Why?
| | Receptors, Progesterone | 1 | 2020 | 326 | 0.650 |
Why?
| | Receptors, Estrogen | 1 | 2020 | 388 | 0.620 |
Why?
| | Disease Models, Animal | 3 | 2021 | 3798 | 0.570 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 329 | 0.560 |
Why?
| | Cell Proliferation | 4 | 2020 | 2361 | 0.490 |
Why?
| | Breast Neoplasms | 3 | 2020 | 1970 | 0.480 |
Why?
| | Xenograft Model Antitumor Assays | 5 | 2021 | 769 | 0.420 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2016 | 0.330 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 450 | 0.300 |
Why?
| | Cell Line, Tumor | 5 | 2019 | 2913 | 0.280 |
Why?
| | Mice, Nude | 2 | 2020 | 682 | 0.210 |
Why?
| | Prognosis | 2 | 2020 | 3601 | 0.210 |
Why?
| | Apoptosis | 4 | 2020 | 2564 | 0.200 |
Why?
| | Heterografts | 1 | 2021 | 135 | 0.190 |
Why?
| | Immunoblotting | 2 | 2018 | 317 | 0.190 |
Why?
| | Indolizines | 1 | 2019 | 4 | 0.190 |
Why?
| | Forkhead Box Protein M1 | 1 | 2019 | 7 | 0.190 |
Why?
| | Immunotherapy | 2 | 2021 | 493 | 0.180 |
Why?
| | Ultrasonic Waves | 1 | 2019 | 4 | 0.180 |
Why?
| | Immune System | 1 | 2021 | 182 | 0.180 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 91 | 0.180 |
Why?
| | Quinoxalines | 1 | 2019 | 65 | 0.180 |
Why?
| | Antineoplastic Agents, Immunological | 2 | 2020 | 159 | 0.180 |
Why?
| | Microbubbles | 1 | 2019 | 40 | 0.170 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 166 | 0.170 |
Why?
| | Immunohistochemistry | 2 | 2020 | 1732 | 0.170 |
Why?
| | Adrenal Cortex | 1 | 2018 | 37 | 0.160 |
Why?
| | Carcinogenesis | 1 | 2019 | 182 | 0.160 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2020 | 195 | 0.160 |
Why?
| | Mice | 5 | 2021 | 15616 | 0.160 |
Why?
| | Cyclin D1 | 1 | 2017 | 63 | 0.160 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 31 | 0.160 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 576 | 0.150 |
Why?
| | Survival Rate | 1 | 2020 | 1828 | 0.140 |
Why?
| | RNA Interference | 1 | 2017 | 476 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2017 | 424 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2020 | 659 | 0.140 |
Why?
| | Phosphorylation | 1 | 2019 | 1684 | 0.130 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1066 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1200 | 0.120 |
Why?
| | Neoplasms | 2 | 2021 | 2241 | 0.120 |
Why?
| | Humans | 11 | 2021 | 121723 | 0.120 |
Why?
| | Signal Transduction | 2 | 2019 | 4810 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 693 | 0.110 |
Why?
| | Animals | 5 | 2021 | 34126 | 0.110 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 292 | 0.100 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4880 | 0.100 |
Why?
| | Mice, SCID | 2 | 2021 | 342 | 0.090 |
Why?
| | Mice, Inbred NOD | 2 | 2021 | 571 | 0.080 |
Why?
| | Protein Binding | 1 | 2013 | 2017 | 0.080 |
Why?
| | Female | 5 | 2021 | 63833 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2013 | 1774 | 0.070 |
Why?
| | Middle Aged | 2 | 2021 | 28928 | 0.060 |
Why?
| | Chimerism | 1 | 2021 | 29 | 0.050 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 67 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 80 | 0.050 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 113 | 0.040 |
Why?
| | Lamin Type B | 1 | 2018 | 6 | 0.040 |
Why?
| | NIMA-Related Kinases | 1 | 2018 | 7 | 0.040 |
Why?
| | Naphthyridines | 1 | 2018 | 17 | 0.040 |
Why?
| | Aldosterone | 1 | 2018 | 46 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 907 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2018 | 343 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 134 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1237 | 0.040 |
Why?
| | Genomics | 1 | 2021 | 687 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 542 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2727 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 576 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 678 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3079 | 0.030 |
Why?
| | Mutation | 1 | 2021 | 3516 | 0.020 |
Why?
|
|
Kar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|